Bob D. Brown
2019
In 2019, Bob D. Brown earned a total compensation of $2.1M as Chief Scientific Officer, Executive Vice President of R&D at Dicerna Pharmaceuticals, a 66% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $214,245 |
|---|---|
| Option Awards | $1,465,200 |
| Salary | $438,856 |
| Other | $18,858 |
| Total | $2,137,159 |
Brown received $1.5M in option awards, accounting for 69% of the total pay in 2019.
Brown also received $214.2K in non-equity incentive plan, $438.9K in salary and $18.9K in other compensation.
Rankings
In 2019, Bob D. Brown's compensation ranked 5,582nd out of 13,971 executives tracked by ExecPay. In other words, Brown earned more than 60.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,582 out of 13,971 | 60th |
Division Manufacturing | 2,090 out of 5,701 | 63rd |
Major group Chemicals And Allied Products | 745 out of 2,200 | 66th |
Industry group Drugs | 625 out of 1,886 | 67th |
Industry Pharmaceutical Preparations | 457 out of 1,398 | 67th |
Source: SEC filing on April 22, 2020.
Brown's colleagues
We found four more compensation records of executives who worked with Bob D. Brown at Dicerna Pharmaceuticals in 2019.